Clinical trials
Side Effects clinical trials
Below are recruiting side effects clinical trials, each written for real people, not researchers. We’re tracking 128 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07169851RecruitingPhase 2
Study of a new drug for chemo nausea and vomiting
This trial tests a medication called LY3537021 to see if it can prevent nausea and vomiting caused by certain types of chemotherapy (AC or cisplatin) in people who have not had chemo before. It focuses on patients who are otherwise in fairly good health.
Greenbrae, CaliforniaAges 18 years+ - NCT07163182RecruitingPhase 1
Safety study of nasal CHF6467 in healthy volunteers
This study tests a new medicine called CHF6467 given as a nasal spray. It looks at how safe the medicine is, how it is absorbed and removed from the body, and what side effects it might cause. Healthy volunteers aged 18 to 55 can take part.
SofiaAges 18–55 - NCT07129525Recruiting
Skin care plan for radiation skin irritation
This trial tests a skin-care plan for people whose skin gets irritated from radiation therapy for head, neck, or pelvic cancers. It aims to reduce redness, discomfort, and other skin side effects during treatment.
Roma, RMAges 18 years+ - NCT07130981Recruiting
Body composition and well-being in cancer patients on ICI therapy
This study looks at how body composition and emotional factors affect cancer patients receiving immune checkpoint inhibitors (ICIs). It may help understand how these factors relate to treatment outcomes.
Ankara, AltındağAges 18 years+ - NCT07116213Recruiting
Shorter radiation after surgery for high-risk endometrial cancer
This trial studies a new type of radiation therapy (called online adaptive radiotherapy) given in shorter, higher daily doses after surgery for high-risk endometrial cancer. The goal is to see if this approach is safe and effective for reducing side effects while still controlling the cancer.
Beijing, Beijing MunicipalityAges 18–70 - NCT07121543Recruiting
Cervical cancer radiation side effect study
This study looks at how cervical cancer and radiation therapy affect the body. It aims to understand why side effects happen, which could lead to better treatment in the future.
La Jolla, CaliforniaAges 18 years+ - NCT05362760RecruitingPhase 4
Abemaciclib plus hormone therapy, with digital side-effect tracking
This trial tests whether adding abemaciclib to standard hormone (endocrine) therapy can improve outcomes for certain types of advanced breast cancer. It also uses a phone app to help you and the team track side effects so problems can be caught early.
AalenAges 18 years+ - NCT07071038RecruitingPhase 2
Switching medication to relieve side effects from aromatase inhibitors
This trial tests whether switching to a different aromatase inhibitor or using standard treatments works better for managing side effects in breast cancer survivors. It aims to help you stay on hormone therapy longer with fewer discomforts.
Lebanon, New HampshireAges 18 years+ - NCT07046650RecruitingPhase 2
Cisplatin plus gemcitabine for rare tumors after PD-1 therapy
This trial tests a combination of two chemotherapy drugs, cisplatin and gemcitabine, for people with certain rare cancers that no longer respond to a type of immunotherapy called PD-1 inhibitors. The goal is to see how well this treatment works and what side effects it may cause.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07035002RecruitingPhase 1
PD-1 knockout TILs for advanced colorectal cancer
This trial tests a new therapy where immune cells (TILs) from your tumor are modified to fight cancer more effectively. It's for people with advanced colorectal cancer who can't get standard treatments.
Shanghai, None SelectedAges 18–70 - NCT07033845RecruitingEarly Phase 1
Absorption Study of Topical Phenylephrine in Healthy Women
This study tests how a topical phenylephrine solution is absorbed through the scalp in healthy women. It aims to understand the drug's safety and how the body processes it.
RomeAges 18–55 - NCT07029906Recruiting
Testing if beta-blocker side effects are due to expectations
This study tests whether some side effects from beta-blockers are caused by your expectations (the nocebo effect) rather than the drug itself. If you have heart failure and stopped a beta-blocker due to symptoms, this study may help understand your experience and potentially find better ways to manage it.
LondonAges 18 years+ - NCT07008716RecruitingPhase 3
Omitting CTV for primary tumor in limited-stage small cell lung cancer
This trial tests whether treating the main tumor alone, without the nearby lymph nodes, can work as well in limited-stage small cell lung cancer after initial chemotherapy. You may qualify if you have not had disease progression after 2-4 cycles of standard chemo and meet other health criteria.
Guangzhou, GuangdongAges 18–75 - NCT06311981RecruitingPhase 2
Carbon ion radiation for elderly lung cancer patients
This trial tests carbon ion radiotherapy for adults 75 and older with locally advanced non-small cell lung cancer who cannot have surgery. The goal is to see if this precise type of radiation can treat the cancer effectively with fewer side effects.
Shanghai, Shanghai MunicipalityAges 75 years+ - NCT06311955RecruitingPhase 2
Carbon ion radiation for residual thymus tumor after surgery
This trial tests a type of radiation called carbon ion therapy for people with thymus cancer that was not completely removed during surgery. The goal is to see if this treatment can target the remaining tumor cells safely and effectively.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06950073Recruiting
Second radiation treatment for lung cancer in the chest
This study tests whether giving a second course of radiation to the chest (called retreatment) can control lung cancer that has come back or a new cancer that started there. People who have already had radiation to their chest and are healthy enough for more may be eligible.
Aarhus, JutlandAges Any age - NCT06828328RecruitingEarly Phase 1
Gene-edited TIL therapy for pancreatic cancer
This trial tests a new treatment called GC203 TIL, which uses your own immune cells (TILs) that have been gene-edited to fight pancreatic cancer. It is for people whose cancer has not responded to standard treatments and who are healthy enough to undergo this therapy.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06725953Recruiting
Remote exercise program for cancer survivors with or without diabetes
This study tests a 12-week home-based physical activity program to see if it helps cancer survivors who had chemotherapy and now have memory or thinking problems. It includes both survivors with type 2 diabetes and those without.
Oklahoma City, OklahomaAges 18 years+ - NCT06719440Recruiting
Better outcome by shrinking radiation target for glioblastoma
This trial tests a smaller radiation target for newly diagnosed glioblastoma to reduce side effects while keeping treatment effective. It may help patients who are healthy enough for standard chemoradiotherapy.
AalstAges 18 years+ - NCT05203250Recruiting
Registry for people treated with heavy particles at CNAO
This registry collects information from people who received heavy particle treatments at the CNAO center. It helps researchers understand outcomes over time, as long as you can understand the study and agree in writing.
PaviaAges Any age - NCT06672471Enrolling by invitation
Antibiotics after head and neck surgery study
This trial tests whether giving antibiotics after certain head and neck surgeries helps prevent infections. It is for people having planned (non-emergency) surgery that involves entering a normally clean area that may have some germs, like the mouth or throat.
Lahore, Punjab ProvinceAges 18 years+ - NCT06669416Recruiting
A study on taste changes during chemotherapy
This study looks at how taste may change when you start chemotherapy for cancer. It aims to help doctors better understand and support patients through these changes.
Chicago, IllinoisAges 18 years+ - NCT05802121RecruitingEarly Phase 1
Testing a gut bacteria supplement side effects during prostate hormone therapy
This early-phase study looks at how changing gut bacteria (especially Akkermansia) affects metabolic side effects in men starting prostate hormone therapy (ADT). It may help researchers understand how to reduce or manage side effects for people on ADT.
London, OntarioAges 18 years+ - NCT06618703Recruiting
Brain radiation in childhood: early hormone check
This study follows children who had brain radiation for cancer to check for early hormone changes. It aims to catch and treat any hormone problems sooner.
AngersAges 4–18
Hear when a new Side Effects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for side effects?
- Yes. Clin2 currently lists 128 recruiting side effects studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a side effects trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a side effects trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.